Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan-Feb;19(1):160-4.
doi: 10.4103/2230-8210.146874.

Assessment of insulin sensitivity/resistance

Manish Gutch  1 , Sukriti Kumar  2 , Syed Mohd Razi  1 , Kumar Keshav Gupta  1 , Abhinav Gupta  1
Affiliations

Assessment of insulin sensitivity/resistance

Manish Gutch et al. Indian J Endocrinol Metab. 2015 Jan-Feb.

Abstract

Insulin resistance is one pretty troublesome entity which very commonly aggravates metabolic syndrome. Many methods and indices are available for the estimation of insulin resistance. It is essential to test and validate their reliability before they can be used as an investigation in patients. At present, hyperinsulinemic euglycemic clamp and intravenous glucose tolerance test are the most reliable methods available for estimating insulin resistance and are being used as a reference standard. Some simple methods, from which indices can be derived, have been validated e.g. homeostasis model assessment (HOMA), quantitative insulin sensitivity check index (QUICKI). For the clinical uses HOMA-insulin resistance, QUIKI, and Matsuda are suitable, while HES, McAuley, Belfiore, Cederholm, Avignon and Stumvoll index are suitable for epidemiological/research purposes. With increasing number of these available indices of IR, it may be difficult for clinicians to select the most appropriate index for their studies. This review provides guidelines that must be considered before performing such studies.

Keywords: Homeostasis model assessment; hyperinsulinemic euglycemic clamp; insulin sensitivity; quantitative insulin sensitivity check index.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No.

References

    1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583–9. - PubMed
    1. Boden G. Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin North Am. 2001;30:801–15. v. - PubMed
    1. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–23. - PubMed
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. - PubMed
    1. Chen H, Sullivan G, Yue LQ, Katz A, Quon MJ. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am J Physiol Endocrinol Metab. 2003;284:E804–12. - PubMed